ScholarIQanswers from OpenAlex

Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia

PaperCitations, authors & open-access status

Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia have?

ScholarIQcitation count

Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia has 731 citations in the OpenAlex counts ScholarIQ stores.

When was Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia published?

ScholarIQyear

Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia has 2020 year in the ScholarIQ index.

What is the open-access status of Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia?

ScholarIQoa status

Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia has green oa status in the ScholarIQ index.

What is the DOI of Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia?

ScholarIQdoi

The DOI for Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia is on the source record.

What is the PMID of Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia?

ScholarIQpmid

The PMID for Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia is on the source record.

What is the OpenAlex record for Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia?

ScholarIQopenalex

The OpenAlex for Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial